Delivery Order SPE2DB25D3003-SPE2DB25FPVDZ

Award Date 11/7/24
Potential Completion Date 11/8/24
Potential Value $7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,869.96, is for the delivery of Adderall 10 mg tablets. It is a firm-fixed-price contract with an ultimate completion date of October 24, 2024. The contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and...
This is a delivery order worth $3,506.94 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Adderall 10 mg tablets. The contract has a performance period that runs through August 20, 2024 and is a firm fixed-price type. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Adderall 10 mg tablets. The contract is a delivery order with a firm fixed price of $2,237.16 and a performance period ending on September 12, 2024. As this contract does not have a set-aside designation, it was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,179.20 firm-fixed-price delivery order covers the supply of Adderall 5 mg tablets for an ultimate completion date of November 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,155.76 firm fixed-price contract is for the supply of Adderall 10 mg tablets. The order has an August 2024 completion date and is not set aside for any special business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation, provides for the delivery of Adderall 10 mg tablets in 100-count packaging to the Defense Logistics Agency (DLA). The $5,093.08 Firm Fixed Price delivery order contract has a performance period through May 29, 2024. This award is likely part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,278.62 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ADDERALL 10 MG TABLET 100S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This federal contract award, valued at $8,814.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of ADDERALL 5 MG TABLET 100S, with a performance period through November 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026,...
This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $2,872.17 delivery order is for the supply of 4,563,895,410 tablets of the medication Adderall 10 mg. The contract is a firm fixed price agreement with a performance period through March 8, 2024. No set-aside designations were used. Amerisourcebergen Drug Corp holds an Indefinite...
This federal contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $38,578.97 delivery order contract is for the supply of Adderall 10 mg tablets. The contract has a firm fixed price and an ultimate completion date of December 9, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB25D3003
    Indefinite Delivery Contract
  • SPE2DB25D3003-SPE2DB25FPVDZ
    Delivery Order

This federal contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $6,981.88, is a delivery order for the supply of 4566373498 ADDERALL 10 MG TABLET 100S. The contract has a firm fixed price and an ultimate completion date of November 8, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not indicate any set-aside designation, suggesting open competition.

Generated 2/6/25, 9:11 AM